Identification and Characterization of a Novel Nanobody Against Human CTGF to Reveal Its Antifibrotic Effect in an in vitro Model of Liver Fibrosis
International Journal of Nanomedicine · 2023
DOI: 10.2147/ijn.s428430 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2023. Verfasst von Rong Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, People's Republic of China. Hauptthemen laut MEDLINE: Connective Tissue Growth Factor, Liver Cirrhosis, Single-Domain Antibodies, Antifibrotic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, People's Republic of China.
- Shanghai Novamab Biopharmaceuticals Co., Ltd, Shanghai, 201318, People's Republic of China.
- Department of Gastroenterology, Shanghai Fourth People's Hospital, Tongji University School of Medicine, Shanghai, 200434, People's Republic of China.
- Department of Gastroenterology, Shanghai Public Health Clinical Center, Fudan University, Shanghai, 201508, People's Republic of China.
Zitieren
APA
Liu, R., Zhu, M., Chen, J., Gai, J., Huang, J., Zhou, Y., Wan, Y., & Tu, C. (2023). Identification and Characterization of a Novel Nanobody Against Human CTGF to Reveal Its Antifibrotic Effect in an in vitro Model of Liver Fibrosis. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s428430
Vancouver
Liu R, Zhu M, Chen J, Gai J, Huang J, Zhou Y, et al. Identification and Characterization of a Novel Nanobody Against Human CTGF to Reveal Its Antifibrotic Effect in an in vitro Model of Liver Fibrosis. International Journal of Nanomedicine. 2023. doi:10.2147/ijn.s428430
BibTeX
@article{Liu2023,
author = {Liu, Rong and Zhu, Min and Chen, Jiaojiao and Gai, Junwei and Huang, Jing and Zhou, Yingqun and Wan, Yakun and Tu, Chuantao},
title = {Identification and Characterization of a Novel Nanobody Against Human CTGF to Reveal Its Antifibrotic Effect in an in vitro Model of Liver Fibrosis},
journal = {International Journal of Nanomedicine},
year = {2023},
doi = {10.2147/ijn.s428430}
}
EUVIMED